Onkologie. 2025:19(1):18-21 | DOI: 10.36290/xon.2025.004

Physical aspects of HDR interstitial brachytherapy planning

Petr Paluska
Klinika onkologie a radioterapie, FN Hradec Králové

High dose rate brachytherapy is realized solely by automatic afterloading irradiators nowadays. The most common are intracavitary and interstitial applications. Cooperation between a physician and a physicist before insertion of applicators is a very important aspect. Changes of applicators' geometry are usually not possible afterwards. A range of imaging modalities can be used for brachytherapy planning. A physical parameters useful for quality assessment and optimization of the plans are presented in this article.

Keywords: HDR brachytherapy, interstitial brachytherapy, radiotherapy planning.

Accepted: February 27, 2025; Published: March 10, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Paluska P. Physical aspects of HDR interstitial brachytherapy planning. Onkologie. 2025;19(1):18-21. doi: 10.36290/xon.2025.004.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 10.3.2026

    References

    1. Steel GG. The Dose-Rate Effect: Brachytherapy. In Basic Clinical Radiobiology; Steel GG, Ed.; Edward Arnold Publishers: London, UK; 1993.
    2. Soumarová R, Homola L. Intersticiální brachyterapie. Brno: Masarykova univerzita; 2006.
    3. ICRU (INTERNATIONAL COMMISSION ON RADIATION UNITS AND MEASUREMENTS): Dose nad Volume Specification for Reporting Interstitial Therapy. Report 58. ICRU, Bethesda, Maryland, USA; 1997.
    4. Major T, Fröhlich G, Ágoston P, et al. The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlenther Onkol. 2022;198:93-109. Available from: https://doi.org/10.1007/s00066-021-01867-1. Go to original source... Go to PubMed...
    5. NCCN guidelines version 4.2024 cervical cancer [Internet]. [cited 2024 Nov 7]. Available from: https://www.nccn.org/guidelines.
    6. Sirák I, Sýkorová P, Grepl J, et al. 4D MR adaptivní brachyterapie karcinomu hrdla dělohy ve FN Hradec Králové. Onkol Revue. 2018;5(6):1-6.
    7. Jiřičková J. Unikátní kombinace léčby dokáže nádor zničit do pěti týdnů. Forum - Magazín Univerzity Karlovy [Internet]. 2022; [cited 2024 Nov 7]. Available from: https://www.ukforum.cz/rubriky/veda/8230-igor-sirak-nador-dokazeme-znicit-behem-peti-tydnu.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.